Hormone Molecular Biology and Clinical Investigation
Editor In Chief:Gérard S. Chetrite
Editorial Board:Michael N. Alexis, Aria Baniahmad, Miguel Beato, Roger Bouillon, Angela Brodie, Giuseppe Carruba, Shiuan Chen, John A. Cidlowski, Robert Clarke, Herjan J.T. Coelingh Bennink, Philippa D. Darbre, Jacques Drouin, Maria L. Dufau, Dean P. Edwards, Charles N. Falany, Leandro Fernandez-Perez, Clotilde Ferroud, Bruno Feve, Amilcar Flores-Morales, Michelle T. Foster, Luis M. Garcia-Segura, Amalia Gastaldelli, Julia M.W. Gee, Andrea R. Genazzani, Geoffrey L. Greene, Bernd Groner, Richard Hampl, Leena Hilakivi-Clarke, Michael Hubalek, Hirotaka Iwase, V. Craig Jordan, Helmut Klocker, Ronald De Kloet, Fernand Labrie, Carole R. Mendelson, Alfred O. Mück, Alejandro F. De Nicola, Bert W. O'Malley, Jean-Pierre Raynaud, Xiangyan Ruan, Jose Russo, Farid Saad, Edwin R. Sanchez, Andrew V. Schally, Roxana Schillaci, Adolf E. Schindler, Gunnar Söderqvist, Valerie Speirs, Frank Z. Stanczyk, Luboslav Starka, Thomas R. Sutter, Jesús A. Tresguerres, Walter Wahli, Ludwig Wildt, Kaiping Yang, and Qi Yu
Most recent research on urgent health issues related to hormones
Thorough selection of top articles within particular fields
Internationally recognized editorial board boosting the prestige of articles
Quick access to issues thanks to ahead of print publishing
Objective Hormone Molecular Biology and Clinical Investigation (
HMBCI) is dedicated to the provision of basic data on molecular aspects of hormones in physiology and pathophysiology. The journal covers the treatment of major diseases, such as endocrine cancers (breast, prostate, endometrium, ovary), renal and lymphoid carcinoma, hypertension, cardiovascular systems, osteoporosis, hormone deficiency in menopause and andropause, obesity, diabetes, brain and related diseases, metabolic syndrome, sexual dysfunction, fetal and pregnancy diseases, as well as the treatment of dysfunctions and deficiencies.
HMBCI covers new data on the different steps and factors involved in the mechanism of hormone action. It will equally examine the relation of hormones with the immune system and its environment, as well as new developments in hormone measurements.
HMBCI is a blind peer reviewed journal and publishes in English: Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers. Ahead-of-print publishing ensures faster processing of fully proof-read, DOI-citable articles.
The superfamily of receptors of the different hormones (steroids, polypeptides and related hormones), and co-regulators (activators and repressors);
Hormones related to the function of growth factors, oncogenes, and cytokines, in normal and neoplastic tissues;
Enzymes and anti-enzymes involved in the formation and disposition of various hormones in connection with the diseases stated above;
Hormone signaling and response to hormone therapy;
Mechanism of cancer cell proliferation under endocrine therapy;
Resistance to hormone therapy and its mechanism;
Hormones and the brain and other neuroendocrine organs;
Hormone replacement therapy;
Pre-clinical studies to test new molecules in isolated models and in human trials;
Hormones and the immune system;
Hormones and the environment;
Initiation and evolution of diseases related to the mechanism of action of hormones;
Therapeutic effect of hormones with regard to the method of administration.
Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers
Once your article is accepted you have the option to publish it open access
Our repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract. Detailed information can be found at Public Repositories tab
If you have any general questions please visit our FAQ page for authors